Independent Factors and Predictive Score for Extrahepatic Metastasis of Hepatocellular Carcinoma Following Curative Hepatectomy

被引:39
作者
Li Jun [1 ]
Yan Zhenlin [1 ]
Gong Renyan [1 ]
Wang Yizhou [1 ]
Wan Xuying [2 ]
Xue Feng [1 ]
Xia Yong [1 ]
Wang Kui [1 ]
Liu Jian [1 ]
Wu Dong [1 ]
Wang Hongyang [3 ]
Shi Lehua [1 ]
Wu Mengchao [1 ,2 ,3 ]
Shen Feng [1 ]
机构
[1] Second Mil Med Univ, Dept Hepat Surg, Eastern Hepatobiliary Surg Hosp, Shanghai 200438, Peoples R China
[2] Second Mil Med Univ, Dept Clin Database, Eastern Hepatobiliary Surg Hosp, Shanghai 200438, Peoples R China
[3] Second Mil Med Univ, Int Cooperat Lab Signal Transduct, Eastern Hepatobiliary Surg Hosp, Shanghai 200438, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepatocellular carcinoma; Hepatectomy; Extrahepatic metastasis; Prediction; Risk factor; HEPATIC RESECTION; RECURRENCE; MANAGEMENT; SORAFENIB; CANCER; TOMOGRAPHY; SURVIVAL; FEATURES; CAPSULE; SPREAD;
D O I
10.1634/theoncologist.2011-0447
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Postoperative extrahepatic metastasis (EHM) contributes to a poor prognosis in patients with hepatocellular carcinoma (HCC) after hepatectomy. This study was aimed to develop a practical method that can be used to predict postoperative EHM. Methods. In total, 578 patients were enrolled. We analyzed the clinicopathological features of the tumors and did a long-term follow-up to observe HCC recurrence. Postoperative DIM was detected in 136 patients, and multivariate analysis was used to confirm independent risk factors for postoperative EHM. After the factors were identified, a predictive scoring system was constructed as a weighted sum of these factors. The cutoff value that determines a high risk for EHM was defined by maximizing the Youden's index of the receiver operating characteristic curve. Results. Microvascular invasion, incomplete capsule, and larger tumor diameter were the three independent factors predictive for a high risk for EHM. The scoring system was derived with an area under the curve (AUC) of 0.81 for postoperative 10-year EHM prediction. A cutoff value of 43 was derived and validated with a sensitivity > 90% and specificity > 60% to predict the development of EHM. This system was further verified in a subgroup of Barcelona Clinic Liver Cancer stage 0-A patients with an AUC of 0.82. When the cutoff value was set at 43, the sensitivity and specificity were 90.38% and 64.88%, respectively. Conclusions. Our predictive scoring system may be used to identify HCC patients who have a high risk for EHM following curative hepatectomy. The Oncologist 2012;17: 963-969
引用
收藏
页码:963 / 969
页数:7
相关论文
共 43 条
[1]  
[Anonymous], ELEMENTS STAT LEARNI
[2]   Management of hepatoceullular carcinoma [J].
Bruix, J ;
Sherman, M .
HEPATOLOGY, 2005, 42 (05) :1208-1236
[3]   Pulmonary resection for metastases from hepatocellular carcinoma [J].
Chen, Fengshi ;
Sato, Kiyoshi ;
Fujinaga, Takuji ;
Sonobe, Makoto ;
Shoji, Tsuyoshi ;
Sakai, Hiroaki ;
Miyahara, Ryo ;
Bando, Toru ;
Okubo, Kenichi ;
Hirata, Toshiki ;
Date, Hiroshi .
WORLD JOURNAL OF SURGERY, 2008, 32 (10) :2213-2217
[4]   Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: A pilot study [J].
Cucchetti, Alessandro ;
Piscaglia, Fabio ;
Grigioni, Antonia D'Errico ;
Ravaioli, Matteo ;
Cescon, Matteo ;
Zanello, Matteo ;
Grazi, Gian Luca ;
Golfieri, Rita ;
Grigioni, Walter Franco ;
Pinna, Antonio Daniele .
JOURNAL OF HEPATOLOGY, 2010, 52 (06) :880-888
[5]   Comparison of Recurrence of Hepatocellular Carcinoma After Resection in Patients with Cirrhosis to Its Occurrence in a Surveilled Cirrhotic Population [J].
Cucchetti, Alessandro ;
Piscaglia, Fabio ;
Caturelli, Eugenio ;
Benvegnu, Luisa ;
Vivarelli, Marco ;
Ercolani, Giorgio ;
Cescon, Matteo ;
Ravaioli, Matteo ;
Grazi, Gian Luca ;
Bolondi, Luigi ;
Pinna, Antonio Daniele .
ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (02) :413-422
[6]  
Edge SB, 2009, AJCC CANC STAGING MA, P237
[7]   Sorafenib Suppresses Postsurgical Recurrence and Metastasis of Hepatocellular Carcinoma in an Orthotopic Mouse Model [J].
Feng, Yu-Xiong ;
Wang, Tao ;
Deng, Yue-Zhen ;
Yang, Pengyuan ;
Li, Jing-Jing ;
Guan, Dong-Xian ;
Yao, Fan ;
Zhu, Yin-Qiu ;
Qin, Ying ;
Wang, Hui ;
Li, Nan ;
Wu, Meng-Chao ;
Wang, Hong-Yang ;
Wang, Xiao-Fan ;
Cheng, Shu-Qun ;
Xie, Dong .
HEPATOLOGY, 2011, 53 (02) :483-492
[8]   Multiple primary malignancies in Spanish patients with hepatocellular carcinoma: Analysis of a hospital-based tumor registry [J].
Fernandez-Ruiz, Mario ;
Guerra-Vales, Juan-Manuel ;
Castelbon-Fernandez, Francisco-Javier ;
Llenas-Garcia, Jara ;
Caurcel-Diaz, Luis ;
Colina-Ruizdelgado, Francisco .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (08) :1424-1430
[9]   Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects [J].
Forner, Alejandro ;
Reig, Maria E. ;
Rodriguez de Lope, Carlos ;
Bruix, Jordi .
SEMINARS IN LIVER DISEASE, 2010, 30 (01) :61-74
[10]  
Galen R S, 1982, Clin Lab Med, V2, P685